EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Therapy-resistant lymphomas may want nucleotides, but they just need to grow

Carlos Carmona-Fontaine

Journal of Clinical Investigation · 15.07.2026 · 136 (14)

DOI: 10.1172/jci208384 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2026. Verfasst von Carlos Carmona-Fontaine. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Lymphoma, B-Cell, Nucleotides, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant cells must rapidly synthesize nucleotides to grow and proliferate. Antimetabolite chemotherapies throw a wrench in this process by administering decoy molecules resembling nucleotide precursors that cells cannot use, such as 6-mercaptopurine (6MP) and methotrexate. While this approach remains an essential tool in the treatment of lymphoblastic leukemias and B cell non-Hodgkin lymphomas, approximately 1 in 3 patients will eventually develop therapy-resistant malignancies. In this issue of the JCI , Yang et al. investigated the metabolic adaptations that enable therapy-resistant tumors to grow in the presence of these drugs. Using their previously described mouse model of MYC-driven large B cell lymphoma, they identified that increased expression of the vesicular oligopeptide and histidine transporter SLC15A3 drives dipeptide accumulation in therapy-resistant cells. In lieu of finding other ways to make more nucleotides, these adaptations force cell growth by boosting mTOR signaling. This cunning adaptation, however, is also a vulnerability that can be targeted clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmLymphoma, B-CellNucleotidesPrecursor Cell Lymphoblastic Leukemia-LymphomaAnimalsHumansMiceCell ProliferationDipeptidesMembrane Transport ProteinsTOR Serine-Threonine KinasesSignal Transduction

Substanzen

DipeptidesMembrane Transport ProteinsNucleotidesSLC15A3 protein, humanSLC15A3 protein, mouseTOR Serine-Threonine Kinases

Zitieren

APA

Carmona-Fontaine, C. (2026). Therapy-resistant lymphomas may want nucleotides, but they just need to grow. Journal of Clinical Investigation, 136(14). https://doi.org/10.1172/jci208384

Vancouver

Carmona-Fontaine C. Therapy-resistant lymphomas may want nucleotides, but they just need to grow. Journal of Clinical Investigation. 2026;136(14). doi:10.1172/jci208384

BibTeX
@article{CarmonaFontaine2026,
  author = {Carmona-Fontaine, Carlos},
  title = {Therapy-resistant lymphomas may want nucleotides, but they just need to grow},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {14},
  doi = {10.1172/jci208384}
}
Kostenlos starten →